, Singapore
341 views
/HSBC Life from LinkedIn.

HSBC Life Singapore bolsters executive team

Both roles will report directly to CEO Harpreet Bindra.

HSBC Life Singapore has made two senior appointments to its executive committee, reinforcing its focus on client-centric services through multi-channel distribution. 

Both roles will report directly to Harpreet Bindra, chief executive officer of HSBC Life Singapore.

Ouling Lu has been named Chief Product Propositions Officer. He will lead the development of new product propositions and manage in-force activities. 

Lu previously served as Head of Products and Propositions across Greater Asia Life for Milliman and held leadership roles at Allianz in Asia, Europe, and the United States over a decade.

Michael Wei has been appointed Chief Partnership Distribution Officer, where he will oversee HSBC Life’s Bancassurance, High Net Worth (HNW), and Independent Financial Advisory channels in Singapore. 

He will also lead the company's Sustainability and Corporate Social Responsibility (CSR) initiatives. Wei brings over 20 years of experience, including his role as Chief Partnership & Marketing Officer at Sun Life Singapore, along with leadership positions at Citi, OCBC, and Manulife, with a focus on the affluent, HNW, and ultra-high-net-worth (UHNW) segments.

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.